NOVAVAX INC (NVAX)
US6700024010 - Common Stock
NOVAVAX INC
NASDAQ:NVAX (12/24/2024, 7:28:52 PM)
After market: 8.5 -0.01 (-0.12%)8.51
-0.13 (-1.5%)
Company Profile
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company is headquartered in Gaithersburg, Maryland and currently employs 1,543 full-time employees. The firm offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. The company has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The firm is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.
Company Info
NOVAVAX INC
700 Quince Orchard Road
Gaithersburg MARYLAND 20878
P: 12402682000
CEO: Stanley C. Erck
Employees: 1543
Website: https://www.novavax.com/?locale=US
NVAX News
9 days ago - Market News VideoNotable Monday Option Activity: AVAV, NKE, NVAX12 days ago - Novavax, Inc.Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced progress in Q4...
19 days ago - Market News VideoNoteworthy Friday Option Activity: NVAX, MTDR, MU21 days ago - The Motley Fool2 Beaten-Down "Pandemic Stocks" to Consider for Contrarian Investors21 days ago - Yahoo Finance2 Beaten-Down "Pandemic Stocks" to Consider for Contrarian InvestorsTelemedicine Teladoc Health (NYSE: TDOC) and vaccine maker Novavax (NASDAQ: NVAX) belong in this group: Both have significantly lagged behind the market since 2021. Teladoc was a leader in the rise of telehealth during the pandemic, allowing patients to receive basic consultations, prescriptions, and referrals from the comfort of their homes. Teladoc also started providing virtual therapy through its BetterHelp segment and various services to those with chronic health illnesses, particularly diabetes, through its acquisition of Livongo.
22 days ago - Novavax, Inc.Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200 Million/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it has signed...
NVAX Twits
Here you can normally see the latest stock twits on NVAX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
